Seagen Inc (SGEN) Dividend History

Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug Conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity. The company's flagship product Adcetris is commercially available for four indications in more than 65 countries, including the U.S., Canada, Japan and members of the European Union.

Last update 08/13/2022


Dividend Yield Summary

  2017 2018 2019 2020 2021 2022
Dividends - - - - - -
Average Price 58.87 62.09 80.28 153.79 158.20 144.74
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2022 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note